SAB Biotherapeutics Inc
SABSW
$0.01+11.96%
End of day · as of Oct 13, 2026, 1:30 AM ET
Mkt cap
$859,979
EV/Sales
N/A
P/E ratio
N/A
FY2025 Revenue
N/A
EPS (H1 2026)
$-0.62
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
N/A
Beta
N/A
Div yield
N/A
Sector
N/A
SAB Biotherapeutics Inc (SABSW) warrant listed on NASDAQ.
Latest reported SABSW revenue for 2025-12-31 was $0. Net income was $13.3M. Revenue was down 100.0% from 2023-12-31 to 2025-12-31. SABSW currently screens at market cap $860.0K.
Use this SABSW research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full SABSW income, balance, and cash tables.
Latest cached SAB Biotherapeutics Inc (SABSW) net income for Dec 31, 2025 was $13.3M. Statements: https://lician.com/financials/sabsw
SAB Biotherapeutics Inc (SABSW) market capitalization is $860.0K on the latest cached snapshot.
SAB Biotherapeutics Inc (SABSW) cached previous close $0.01; day range $0.01 – $0.01; volume 2,122. Session quote: https://lician.com/quote/sabsw
The latest cached SABSW filing is 8-K · Oct 13, 2026. Filings: https://lician.com/sec/sabsw